Cel-sci presentation at ld micro "main event" available on tuesday, october 21, 2025

Vienna, virginia--(newsfile corp. - october 20, 2025) - cel-sci corporation (nyse american: cvm), a clinical stage cancer immunotherapy company, previously announced that geert kersten, chief executive officer, is scheduled to present at the ld micro "main event" investor conference on october 21, 2025. you can register to watch the virtual presentation at 9:30 a.m.
SCI Ratings Summary
SCI Quant Ranking